(Q39585585)

English

Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts

scientific article published on November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

1 reference

based on heuristic

author name string

Roth-Eichhorn S

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Schade I

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Kasper M

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ploetze K

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Wunderlich J

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Funk RH

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Schueler S

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

1 reference

based on heuristic

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

The Journal of Heart and Lung Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1188-1198

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Constrictive (obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection enhances experimental obliterative bronchiolitis in rat tracheal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of complement inhibits obliterative bronchiolitis in rat tracheal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchiolitis obliterans: pathogenesis, prevention, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical characterization of inflammatory and proliferative events during chronic rejection in rat lung allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of new immunosuppressive therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

PDE isoenzymes as targets for anti-asthma drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transduction in inflammatory processes, current and future therapeutic targets: a mini review.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of myofibroblast and smooth-muscle phenotypes in the lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic rejection: an update on the mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of respiratory epithelium in a rat model of obliterative airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of transforming growth factor-beta in transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Does cyclosporin promote the secretion of transforming growth factor-beta 1 following pulmonary transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900340-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1053-2498(01)00340-0

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

release_v3js2rg3nze3ph5lqlbq45jwau

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39585585&oldid=1842460866"